Comparative Assessment of Modern Fluoroquinolones Efficacy in Experimental Tularemia Treatment

Comparative Assessment of Modern Fluoroquinolones Efficacy in Experimental Tularemia Treatment

The comparative assessment of fluoroquinolones efficacy in experimental tularemia treatment was carried out. Sparfloxacin, pefloxacin and moxifloxacin were shown to be highly effective when treating this disease in test animals.

Bibliographic Details
Main Authors:	T. A. Bondareva, L. V. Kalininsky, I. V. Borisevich, G. V. Baramzina, O. O. Fomenko
Format:	Article
Language:	Russian
Published:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2008-06-01
Series:	Проблемы особо опасных инфекций
Subjects:	tularemia test animals fluoroquinolones susceptibility of pathogens efficacy sparfloxacin pefloxacin moxifloxacin
Online Access:	https://journal.microbe.ru/jour/article/view/1037

Similar Items

Quinolone Susceptibility in Salmonella Isolates Based on Minimum Inhibitory Concentration Determination
by: Varsha Gupta, et al.
Published: (2020-12-01)

Аrginase/NO-synthase system сharacteristics in blood lymphocytes under effect of fluoroquinolones
by: І. V. Кovalenko, et al.
Published: (2019-05-01)

Photodegradation of sparfloxacin and isolation of its degradation products by preparative HPLC
by: H.R.N. Salgado, et al.
Published: (2005-01-01)

Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in India
by: Priyanka Sharma, et al.
Published: (2017-01-01)

Isolation of GAL Tularemia Bacteriophage and its Characteristics
by: A. A. Grigor’ev, et al.
Published: (2008-08-01)

Tularemia in children
by: E. O. Utenkova, et al.
Published: (2019-07-01)

A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use
by: A.P. Vignesh, et al.
Published: (2015-02-01)

Fluoroquinolone-Induced Aortic Injury
by: N. V. Izmozherova, et al.
Published: (2021-07-01)

Quinolone Safety and Efficacy More Important than Potency
by: Richard Frothingham
Published: (2004-01-01)

A Rare Presentation in Tularemia: İnguinally Located Glandular Tularemia
by: Ayşe SAĞMAK TARTAR, et al.
Published: (2017-12-01)

Tularemia as a cause of cervical lymphadenitis
by: Ahmet Eyibilen, et al.
Published: (2011-03-01)

Development and Validation of a HPLC Method for Determination of Pefloxacin in Tablet and Human Plasma
by: Shahnaz Gauhar, et al.
Published: (2009-03-01)

Tularemia as a cause of lymphadenopathy in adults and children
by: E. O. Utenkova, et al.
Published: (2019-10-01)

Tularemia in Arkhangelsk region: clinical and epidemiological aspects
by: L. V. Titova, et al.
Published: (2016-07-01)

Moxifloxacin Induced Seizures -A Case Report.
by: Jiana Shi, et al.
Published: (2014-09-01)

Fluoroquinolone Susceptibility of Campylobacter Strains, Senegal
by: Eric Cardinale, et al.
Published: (2003-11-01)

Tularemia in the world
by: T. Yu. Kudryavtseva, et al.
Published: (2021-03-01)

Detection of sparfloxacin based on water-soluble CuInS2 quantum dots
by: Jiajia Fang, et al.
Published: (2020-01-01)

Assessment of “Specific Safety” Index of the Live Tularemia Vaccine
by: I. S. Barulina, et al.
Published: (2009-02-01)

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
by: Lisa Trieu, et al.
Published: (2015-03-01)

An <i>in vitro</i> study of the susceptibilities and growth dynamics of common ocular pathogens using five fluoroquinolones
by: Hedlin, Peter David Skarsgard
Published: (2005)

Special topic on Francisella tularensis and tularemia
by: Anders eSjostedt
Published: (2011-04-01)

Penetration of 0.3% ciprofloxacin, 0.3% ofloxacin, and 0.5% moxifloxacin into the cornea and aqueous humor of enucleated human eyes
by: G.C.M. Silva, et al.

Tularemia and the oculoglandular syndrome of Parinaud
by: Emine Elif Altuntas, et al.

Characteristics of Tularemia in Kosovo 2010
by: Mr.Sc. Izet Sadiku, et al.
Published: (2011-12-01)

A Rare Case of Tularemia Complicated by Rhabdomyolysis with a Successful Outcome
by: Ieva Kubiliute, et al.
Published: (2021-05-01)

Pharmacokinetics of topically applied sparfloxacin in rabbits
by: Satia Milan, et al.
Published: (2005-01-01)

Peculiarities of the Effect of the Lipopolysaccharide of Tularemia Microbe of Different Subspecies upon Metabolic Activity of Phagocytes <i>in Vitro</i>
by: V. I. Dubrovina, et al.
Published: (2011-04-01)

A Case of Oropharyngeal Tularemia Associated with Erythema Multiforme
by: Saygın NAYMAN ALPAT, et al.
Published: (2013-09-01)

Forgotten Diagnosis in Emergency Service : Tularemia
by: Mehmet Yigit, et al.
Published: (2015-03-01)

Oculoglandular tularemia: A case report
by: Fatmagül Başarslan, et al.
Published: (2012-03-01)

Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats
by: K.A. Sadariya, et al.
Published: (2010-01-01)

Rational therapy of pelvic inflammatory disease
by: A L Tikhomirov
Published: (2014-02-01)

Epizootiologic Monitoring of Natural Focus of Tularemia in the Stavropol Region in 2010-2017
by: E. V. Gerasimenko, et al.
Published: (2020-01-01)

Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors
by: W. Michael Scheld
Published: (2003-01-01)

ANTIBIOTIC THERAPY FOR ENT INFECTIONS
by: A. B. Turovsky, et al.
Published: (2014-07-01)

ANTIBIOTIC THERAPY FOR ENT INFECTIONS
by: A. B. Turovsky, et al.
Published: (2014-07-01)

Development, Phenotypic Characterization and Genomic Analysis of a Francisella tularensis Panel for Tularemia Vaccine Testing
by: Beth A. Bachert, et al.
Published: (2021-08-01)

Treatment-failure tularemia in children
by: Arzu Karlı, et al.
Published: (2018-02-01)

Pefloxacin Residues in Tissues and Organs of Treated Rabbits
by: Mona Abou El-Nil
Published: (2008-03-01)